Introduction
The Endosomal Sorting Complexes Required for Transport are a set of four cytoplasmic protein complexes (ESCRT -0 to III), conserved from yeast to human. ESCRTs are central to a growing range of cellular activities, including the delivery of down-regulated surface proteins to the lumen of late endosomes ( ; ), the release of viruses at the plasma Emr, 2006 Slagsvold et al., 2006 membrane ( ), cytokinesis of dividing cells ( ), and autophagy of protein von Schwedler et al., 2003 Carlton and Martin-Serrano, 2007 aggregates ( ). All of these diverse processes involve the budding and fission of cellular membranes, which appear Filimonenko et al., 2007 to be directly catalysed by ESCRTs. Recent results show that ESCRTs are sequentially recruited to the cytosolic side of endosomal or plasma membrane microdomains, until ESCRT-III subunits locally polymerise into filaments. Transient assembly of ESCRT-III filaments on the membrane is a physical agent of membrane deformation and vesiculation ( ; ; Fabrikant et al., 2009 Hanson et al., 2008 ; ; ; ) . Hence, ESCRT-III polymers are pivotal Muziol et al., 2006 Saksena et al., 2009 Wollert et al., 2009 Wollert and Hurley, 2010 effectors of cellular membrane restructuring.
In keeping with its potent effects, the polymerisation of ESCRT-III is normally under tight regulation. The core subunits of ESCRT-III form a family of highly related proteins, the Charged Multivesicular body Proteins (CHMP) 1 7, all of which contain a conserved -oligomerisation and lipid binding interface (the ESCRT-III or SNF-7 domain), linked to a C-terminal regulatory region (see ). This Fig. 1 latter mediates both intramolecular inhibition of the ESCRT-III domain and intermolecular interaction with subunit-specific factors that regulate filament dynamics ( ; ; ; ). Deletion Bajorek et al., 2009 Muziol et al., 2006 Stuchell-Brereton et al., 2007 Zamborlini et al., 2006 of the regulatory region converts ESCRT-III subunits into dominant negative mutants, able to block ESCRT-dependent processes such as the release of HIV-1 virions from infected cells ( ). Zamborlini et al., 2006 Among ESCRT-III subunits, CHMP2B has received particular attention following the discovery that mutations in the gene CHMP2B underlie a dominantly heritable form of frontotemporal dementia (called FTD-3), a presenile brain disease due to selective degeneration of cortical neurones ( ). In a thoroughly studied Danish kindred, the FTD phenotype was tightly linked to a single point Skibinski et al., 2005 mutation at the splice acceptor site of exon 6. The mutation generates two distinct aberrant transcripts, and CHMP2B CHMP2B intron5
, both of which encode proteins with a defective C terminus ( ) (see ). Neurodegeneration has CHMP2B Δ 10 Skibinski et al., 2005 Fig. 1 been hypothesized to result from perturbation of neuronal autophagy by these mutants subunits ( ). Consistent Rusten and Simonsen, 2008 with the loss of the regulatory domain, in heterologous cells, both CHMP2B
and CHMP2B form insoluble polymers, often coating ; ; ). In cultured cortical neurones, overexpression of CHMP2B was shown to induce al., Lee et al., 2007 Skibinski et al., 2005 retraction of dendritic arbors and subsequent cell death, partly through toxic build-up of autophagosomes ( ; Lee et al., 2007 Lee and Gao, ) . Surprisingly, however, CHMP2B failed to increase neuronal death, even though in heterologous cells, its effects on autophagy 2009 10 Δ are similar to those of CHMP2B ( ). Furthermore, knock-down of CHMP2B by RNAi did not modify intron5 Filimonenko et al., 2007 neuronal viability. These observations suggest that disease-linked CHMP2B mutations may affect neuronal physiology by ways other than lethal malfunction of autophagic mechanisms.
Accumulating evidence indicates that in various neurodegenerative diseases neuronal death is a late event, preceded by early disruption of dendritic spines and synapses, which itself is a pivotal pathogenic step ( ; ; Morfini et al., 2009 Wei et al., 2009 . In FTD, extensive synaptic loss and reduction of spines have been documented in diseased cortex ( ; Ferrer, 1999 . Given its role in endosomal traffic and plasma membrane deformation, ESCRT-III may plausibly control aspects of synaptic 2001 biology. Here, we examine the possible impact of CHMP2B mutants and CHMP2B depletion on the development of dendritic spines.
CHMP2B
and CHMP2B could be expressed in hippocampal neurones without causing apparent anomalies in endosomal intron5 10 Δ morphology, autophagosome amount, or cell viability. The mutants potently suppressed the growth of spine heads, strongly lowering the proportion of mushroom spines. Very similar effects were obtained with an siRNA targeting endogenous CHMP2B, consistent with dominant-negative action of the mutants. Physiologically, CHMP2B caused a drop in the frequency and amplitude of spontaneous 10 Δ excitatory synaptic currents, with selective disappearance of large currents. We propose that CHMP2B and potentially ESCRT-III are required for the maturation of dendritic spines, and that pathogenic CHMP2B mutants perturb this process. To the extent that maturation correlates with functional potentiation, these results implicate ESCRT-III in synaptic plasticity. In the protracted course of FTD, CHMP2B
mutations may affect synaptic homeostasis and plasticity long before inducing massive neuronal death.
Materials and Methods

Plasmids and antibodies
The mCherry plasmid was a kind gift from P. Dournaud (INSERM, Paris). The LC3-GFP plasmid was a kind gift from T. Yoshimori (National Institute of Genetics, Mishima, Japan). The GFP plasmid was pEGFP-C1 (Clontech). The wild-type human CHMP2B cDNA was cloned from HeLa cells by RT-PCR, in frame with an N-terminal dimeric HA tag, using the following primer pair: 5′
TACTCGAGCTGCAGTCACTAATCTACTCCTAAAGCCTTGAGT 3;. The CHMP2B mutant cDNA was amplified from the same intron5 cDNA preparation, using an alternate rearward primer (5; TACTCGAGTCACACCTTTCCAGAAATTTCAAT 3;). The two cDNAs were subcloned in pcDNA3.1 between the XhoI sites. To obtain the CHMP2B cDNA, the C-terminal part was first synthesized in vitro using
10
Δ m e g a p r i m e r s ( 5 ; ATGCCCAGGATATTGTGAATCAAGTTCTTGATGAAATTGGAATTGAAATTTCTGGAAAGGTGTTGCACCAACTTCTAGAAGCTTACC 3 ; a n d 5 ; TAATCTTGAATTGCCATTTAGACGCTTCATCTGTGATGTAGACGTTGTAGTAAAGGTAAATGGTAAGCTTCTAGAAGTTGGTGCAAC 3;) and then fused with the CHMP2B cDNA. The cDNAs was subcloned in pcDNA3.1 between the EcoRV and NotI sites. The intron5 pSuper-mCherry plasmid was constructed by removing GFP from pSuper-Neo-GFP (Oligoengine) and replacing it with mCherry. The shRNA targeted the rat CHMP2B sequence at positions 578 596 (5; GACACTACAAACAATGCAG 3;) according to ( ),
- Lee et al., 2007 and the encoding oligonucleotide was cloned between the Hind III and Bgl II sites of pSuper-mCherry. The RNAi resistant CHMP2B cDNA was generated by introducing four silent mutations in the target sequence (yielding 5; GACGTTACAGACGATGCAA 3;) by means of the Quick-Change mutagenesis kit (Stratagene). All plasmids were verified by sequencing (Cogenics, Meylan, France) and initially tested in transfected BHK cells by immunoblotting and immunofluorescence with anti-tag antibody. The following polyclonal antibodies were purchased from Abcam (Cambridge, UK): anti-CHMP2B, anti-EEA1, anti-LAMP1. Anti-HA tag antibody was from Cell
Signaling Technology (Beverly, Massachussets); anti-myc tag antibody from Santa Cruz (California); and anti-actin antibody from
Chemicon.
Neuronal culture and transfection
Primary cultures of hippocampal neurones were prepared according to a modification of the procedure described in (Banker and ) . Handling and sacrifice of animals were in conformity with European law (EEC Directive n 86/609) and the internal Goslin, 1998 °r egulations of INSERM. Hippocampi were dissected out from E19 rat embryos, digested with trypsin, and hippocampal cells were seeded at a density of 12,000 per cm onto acid-washed glass coverslips (13 mm diameter, Marienfeld, Germany) that had been precoated with 50 2 g/ml poly-D-lysine (Sigma). Cultures were maintained in serum-free Neurobasal medium containing 2 mM glutamine, 1 mM sodium μ pyruvate, 10 g/ml penicillin and streptomycin, and 2 B27 supplement (Invitrogen). For transfection, all plasmids were purified using μ % the Endotoxin-free purification kit (Quiagen, Hilden, Germany minimal when transfected at the dose used here. The conditioned culture medium was removed and saved and coverslips were placed in 2 ml Minimal Essential Medium (Invitrogen) containing 2 mM glutamine, 1 mM sodium pyruvate, 15 mM Hepes: NaOH (pH 7.35). 0.5 g μ CHMP2B plasmid (or control vector) was mixed with 2.5 g mCherry, GFP, or LC3-GFP plasmid, diluted into 250 l transfection μ μ medium, and combined with 1.5 l of Plus Reagent and then 4 l Lipofectamine LTX (Invitrogen). The mixture was incubated for 25 min μ " " μ at room temperature, then added to the dishes, which were left to incubate at 37 C for 1h. The transfection solution was removed and the°c onditioned medium was returned to the dishes. 20 60 neurones per coverslip were usually transfected.
-
Fixation and immunostaining
The coverslips were rinsed in PBS and incubated for 8 min in PBS containing freshly prepared 4 p-formaldehyde and 4 sucrose at % % room temperature (RT). After 3 4 washes in PBS, the cells were permeabilised by incubating in PBS containing 0.3 Triton X-100 for 10
-% min at RT. After washing, coverslips were pre-incubated in blocking solution (PBS containing 2 goat preimmune serum and 1 bovine % % serum albumin (Sigma-Aldrich)) for 1 h, then in blocking solution containing 0.5 1 g/ml primary antibody (or antibody mixture) at RT.
-μ
After washing, incubation with secondary antibody conjugated to Alexa488 or Alexa594 (Molecular Probes, 0.2 g/ml) and final washes, μ coverslips were gently dried, and mounted on slides in Mowiol medium. The specificity of immunofluorescence was routinely verified by staining control cultures that had been transfected with empty pcDNA vector (for anti-tag antibodies) or by omitting the primary antibody in control incubations. The specificity of CHMP2B antibody was further confirmed by RNAi-mediated extinction of immunofluorescence.
Microscopy
Images of fluorescent neurones were acquired with a Leica SP-E laser scanning confocal microscope equipped with a 100 Leica dynamically set for each local sampling of the dendrite surface by the Isodata segmentation algorithm implemented in NeuronStudio. The seed location for automatic dendrite tracing was typically set near the base of a major proximal dendrite. At bifurcation points, the attach ratio was 1.5 and neurites shorter than 5 m were not retained. After modelling of the dendrite surface, protrusions with a minimum μ volume of 5 voxels (0.020 m ), length comprised between 0.2 m and 3 m, and a maximal width of 3 m were retained as spines.
Following defaults settings of the program and the empirical classification rule defined by ( ), spines with minimum Rodriguez et al., 2008 head diameter of 0.35 m and minimum head vs. neck ratio of 1.1 were classified as mushroom spines. Non-mushroom spines with μ minimum volume of 10 voxels (0.040 m ) were classified as stubby spines. All other spines were considered thin. The typical μ 3 percentages of the three spine types which we obtained were close to those found by ( ). Measurements obtained by Rodriguez et al., 2008 NeuronStudio were transferred to a spreadsheet (Excel or Gnumeric) for analysis. Sholl analysis was also performed with NeuronStudio, using single-plane, lower magnification views centred on the cell soma. For each neurone, a series of 2 m-spaced concentric circles μ centred on the soma were drawn as reference marks, starting with a circle just large enough to enclose the cell body. The total length of neurites comprised within two consecutive circles was measured, and the measurement was repeated for increasingly large circle radii.
Stepwise increases in neuritic length were plotted as a function of radial distance from the soma.
Cell degeneration assay
Neurones were transfected with 0.5 g CHMP2B plasmid and 2.5 g mCherry as above. After fixation and mounting onto slides, -°W
estern immunoblotting
Neurones were plated in plating medium at a density of 24, 000 cells per cm onto 35 mm plastic dishes (Nunc) that had been 2 pre-coated with 50 g/ml poly-D-lysine, and grown as described for coverslips. Sister dishes were withdrawn at the indicated time points μ and cells were lysed in lysis buffer containing 1 Triton-X100, 0.2 SDS, 10 mM NaF, 10 mM -glycerophosphate (pH 7.5) and
protease inhibitor mixture (Complete, Roche Molecular), and frozen. All lysates from a given culture were loaded on the same 10% SDS-polyacrylamide gel (10 g total protein per lane) and analysed by electrophoresis and immunoblotting with anti-CHMP2B antibody μ and anti-actin antibody. Bands were revealed by chemiluminescence (Pierce Femto reagent). Luminographs were scanned (300 dpi, 8-bit scale) and the resulting image files were analysed with Metamorph. Grey levels measured for CHMP2B bands were normalized to the corresponding actin bands.
Statistical analysis
The statistical significance of overall variations within sets of conditions was determined by one-way ANOVA. The significance of pair-wise differences between conditions was then assessed by post-hoc one-tailed t tests using the Bonferroni method. Unless indicated otherwise, all the reported p values refer to the difference with the control condition. We verified that criteria for robust ANOVA were satisfied; moreover Kruskal-Wallis analysis of mean rank variance yielded the same qualitative results as ANOVA. For analysis of mEPSC frequency, the significance of the transfection effect was confirmed by two-way ANOVA on a balanced subset of mEPSCs, separating the effect of plasmid identity from intrinsic neurone-to-neurone variation due to the variability of innervation in the culture. The significance of differences between multiple frequency distributions was assessed with the test. A post-hoc test of pairwise differences 
Results
Expression of CHMP2B variants in hippocampal neurones
To study the neuronal effects of CHMP2B proteins, hippocampal neurones were transfected at 10 DIV with plasmids encoding N-terminally tagged CHMP2B , CHMP2B , or CHMP2B ( ). Using immunofluorescent staining with anti-tag antibody, independent investigators, we could not detect any autophagy-associated drop in the diffuse pool of LC3-GFP. Thus in the present setting, pathogenic CHMP2B mutants did not significantly enhance autophagosome accumulation. Furthermore, to determine whether the mutant CHMP2B puncta observed in transfected neurones were related to endosomes, transfected neurones were doubly stained with anti-tag antibody, and antibodies raised against the early endosomal marker EEA-1 ( ) or the late endosomal/lysosomal protein Fig. 3, a2 c2 -LAMP-1 ( ), respectively. No colocalisation was observed with these markers. These data suggest that the CHMP2B Fig. 3, d2 f2 aggregates which form under our transfection conditions are not associated with endosomes.
To visualize the morphology of neurones that had been expressing mutant CHMP2B for several days, the cells were co-transfected with CHMP2B constructs and a plasmid encoding fluorescent protein mCherry, allowing staining of the whole cytosol. Five days after transfection, 75 80 of neurones co-transfected with empty vector, CHMP2B , or CHMP2B
, and 55 of neurones co-transfected -% wt 10 Δ % with CHMP2B were healthy as judged from the overall integrity of their neurites and the absence of neuritic swellings ( ). These percentages did not change much after 10 days, and were largely sufficient to allow meaningful analysis of dendritic arbors and spines. Only healthy neurones were retained for further analysis. The effect of CHMP2B constructs on dendritic arborisation was determined by Sholl analysis of neuronal morphology. For this, we measured the rate of increase in total neuritic length as a function of radial distance from the cell body ( ). CHMP2B and CHMP2B had no significant effect on arborisation. CHMP2B Fig. S2 wt 10 Δ intron5 induced a moderate (25 ) decrease in average branching rate, but not the large-scale retraction of dendrites that accompanies lethal % perturbations of ESCRT-III ( ). Lee et al., 2007 
CHMP2B mutants affect dendritic spine density and morphology
The dendritic morphology of neurones co-transfected with mCherry and CHMP2B plasmids was examined in detail by 3D confocal imaging of mCherry fluorescence.
shows representative views of neurones transfected with the different CHMP2B Fig. 4A(a d) constructs. Stacks of serial optical sections were produced for each neuron and the NeuronStudio software package (Rodriguez et al., 2008 ;  ) was then used to generate three-dimensional reconstructions of dendritic arbors and spines, and to count, measure Rodriguez et al., 2006 and classify spines (see Materials and Methods).
shows a reconstructed dendritic segment obtained from a typical control neurone, Fig. 4B and the results of automated identification of spine types. The volumes of the reconstructed spines followed a statistical distribution which closely resembled that described in a recent study of hippocampal spine dynamics ( ) ( ). Furthermore, the Yasumatsu et al., 2008 Fig. S3 peak of our distribution (between 0.050 and 0.075 m ) was in the same range as published values (0.058 / 0.034 m ) previously
obtained by electron microscopy for the spines of hippocampal neurones in dissociated culture at 14 DIV ( ). The Boyer et al., 1998 distribution of spine lengths was also similar to previously published values ( ). These data indicate that analysis by NeuronStudio Fig. 4G correctly detected the spine population in our cultured neurones.
The density of spines (pooling all spine types) detected by this technique was determined for each neurone ( ). Fig. 5A , B Over-expression of tagged, wild-type CHMP2B did not change the average density compared to control (cotransfection with empty vector). By contrast, expression of CHMP2B raised the average density of spines by 64 compared to control ( , col.3). However, many of these additional spines were very small (see below). Neurones expressing the CHMP2B mutant also had a tendency 10 Δ to increase the density of their protrusions (average density 24 higher), but this trend did not reach significance ( , col. 4). To shows that neurones expressing either mutant had an abnormally low fraction of mushroom spines, identified by their head vs. neck width ratio. The fraction of spines with mushroom morphology was decreased by ~50 with both CHMP2B and CHMP2B , as they 
A CHMP2B mutant affects miniature excitatory synaptic currents
To determine whether the effects of mutant CHMP2B on spine morphology correlated with functional changes at synapses, we recorded excitatory synaptic currents from cultured hippocampal neurones that had been co-transfected with GFP together with empty vector, or with vectors encoding wild-type CHMP2B or CHMP2B . Transfected cells were identified by GFP fluorescence. We amplitude histograms indicated that CHMP2B caused a significant reduction in the frequency of large amplitude events, i.e. those belonging to the top quintile ( ). mEPSCs with amplitude larger than 20 pA (approximately twice the median amplitude), which Fig. 6D represent up to 19 of mEPSCs in control neurones, were reduced by a third in neurones expressing CHMP2B
. Conversely, in these observed reduction in mushroom spines. Mutant CHMP2B may cause a reduction in the proportion of the more potent synapses, and an increase in the proportion of weak synapses.
Endogenous CHMP2B is required for maturation of dendritic spines
As dysregulated CHMP2B mutants affect spine morphogenesis, the question arises whether the endogenous normal protein plays some role in this process. Endogenous CHMP2B was clearly detectable in extracts from cultured neurones at 8 DIV, and increased in older cultures, in which synaptogenesis and spine maturation are known to take place ( ). Immunofluorescent staining of the neurones with Fig. 7 the anti-CHMP2B antibody showed the protein to be widely distributed throughout soma, axons and dendrites, similar to data obtained with the tagged wild-type protein ( ). To disrupt endogenous CHMP2B expression, we transfected cultured hippocampal neurones at Fig. 8 10 DIV with a pSuper-based plasmid vector encoding a previously described CHMP2B-specific shRNA ( ). The efficiency Lee et al., 2007 of RNAi was ascertained by Western blotting of transfected BHK cells ( ). Transfected neurones could be tracked and outlined by Fig. 8A mCherry, co-expressed from the same plasmid. Immunofluorescent staining with anti-CHMP2B antibody confirmed the efficient down-regulation of endogenous CHMP2B expression in transfected neurones ( , middle panel). In agreement with published results Fig. 8B ( ), the CHMP2B shRNA did not affect neuronal viability. To verify the target specificity of RNAi, control experiments Lee et al., 2007 were performed in which CHMP2B shRNA was co-expressed with an RNAi-resistant CHMP2B mRNA (called CHMP2B ) ( , * Fig. 8B lower panel). Confocal imaging of mCherry and spine analysis were performed as in the case of mutant CHMP2B ( , ). Fig. 8C Fig. 9 Depletion of endogenous CHMP2B increased the average density of spines, and the increase was fully reversed upon rescue by
CHMP2B (
). CHMP2B depletion did not significantly affect the length of spines ( ). In contrast, a highly significant * Fig. 9A ,B Fig. 9C , D reduction in mean spine diameter per neurone was observed in shRNA-transfected cells compared to controls; this was rescued to a near-normal value upon co-expression of CHMP2B ( ). Similar to the case of neurones transfected with mutant CHMP2B, the * Fig. 9E ,F size distribution of spine heads showed a loss of the large spine subset; this loss was largely reversed by rescue with RNAi-resistant
). Spine classification revealed a two-fold drop in the average proportion of mushroom spines, from 17 in control ). This effect is equivalent to that observed upon expression of mutant CHMP2B.
%
Fig. 9H
Upon co-expression of CHMP2B , the average proportion of mushroom spines could be rescued to 13 , at which level the difference with * % control neurones was no longer significant ( ). This demonstrates the specificity of CHMP2B shRNA effects. Taken together, these Fig. 9H results indicate that CHMP2B is required for spine head expansion, a basic structural aspect of synaptic plasticity. Furthermore, the data suggest that human disease-linked CHMP2B mutants act as dominant negatives with respect to CHMP2B function in spine morphogenesis.
To determine whether mutant CHMP2B could perturb the subcellular distribution of the normal endogenous protein, neurones transfected with tagged CHMP2B or CHMP2B were immunostained with both anti-CHMP2B and anti-tag antibodies ( ). For this, we took advantage of the fact that the anti-CHMP2B antibody was raised against the wild-type C-terminal region, and therefore does not recognise the mutant proteins. The larger CHMP2B aggregates recruited conspicuous amounts of the endogenous protein, intron5 inducing it to form abnormal clusters (upper panel, arrow) . Faint clusters of CHMP2B also occasionally overlapped with CHMP2B 10 Δ puncta (lower panel). However, the major, diffuse pool of endogenous CHMP2B remained unaffected. These results suggest that a fraction of native CHMP2B molecules may be perturbed in their biochemical function by interaction with mutant protein.
Discussion
Here we found that in cultured hippocampal neurones, two FTD-linked CHMP2B mutants strongly perturbed the normal pattern of dendritic spine development. Both mutants caused a striking decrease in the proportion of large spines with mushroom morphology, i.e.
those associated with potentiated synapses. This outcome was not associated with cell death. In keeping with these results, CHMP2B 10 Δ induced a loss of large mEPSCs, namely those reflecting the activity of the strongest synapses. Consistent with the view that CHMP2B mutants act as dominant negatives, depletion of endogenous CHMP2B by RNAi resulted in changes which were very similar to those induced by mutant CHMP2B, and which could be largely suppressed by co-expression of rescuing protein. Together, these data show that normal spine morphogenesis requires CHMP2B, and that abnormal stoichiometry or pathological dysregulation of the protein can deeply affect the structure and function of spines.
Overexpression of CHMP2B in neurones has previously been shown to trigger a specific toxic process, leading to dramatic intron5 retraction of dendritic trees, followed by cell death after 2 3 days; this lethality has been linked to excessive accumulation of maturation described here occurs through a mechanism distinct from this toxic process. First, the changes in spine morphology were observed in healthy neurones. In particular, expression of CHMP2B or knock-down of endogenous CHMP2B potently affected spines, 10 Δ even though these perturbations of CHMP2B activity did not diminish neuronal viability, as expected from published data. Lee et al., 2007 Lee and Gao, 2009 ). Beyond some threshold level of expression, the ability of CHMP2B mutants to block the ESCRT-dependent fusion of autophagosomes to lysosomes ( ; ) may favour the proliferation of toxic autophagosomes. The difference with Filimonenko et al., 2007 Urwin et al., 2010 our results may arise in part from the relatively low level of mutant CHMP2B expression we used in hippocampal neurones. Indeed, with four-fold higher amounts of CHMP2B plasmid, leading to higher expression, we observed toxicity similar to that described by Alternatively, spine growth may require direct deformation of the dendritic plasma membrane by CHMP2B-containing ESCRT-III filaments ( ; ), or coupling of the actin cytoskeleton to ESCRT-III ( ; Hanson et al., 2008 Sweeney et al., 2006 Sevrioukov et al., 2005 ). Identification of CHMP2B-binding dendritic proteins and observation of ESCRT-III dynamics in live neurones may Vaccari et al., 2009 shed light on these possibilities.
Looking for a functional correlate of the CHMP2B effect, we found that this mutant significantly decreased the frequency of 10 Δ mEPSCs. This result indicates that CHMP2B elicits a decrease in synaptic activity. Moreover, the mutant induced a significant drop (32 10 Δ ) in the proportion of large mEPSCs. The two observations are in keeping with the loss of mature post-synaptic spines. In view of the % general correlation between spine size and synaptic potency ( ), the change in synaptic properties is consonant with Matsuzaki et al., 2001 the reduction in the proportion of mushroom spines induced by CHMP2B
. This result raises the intriguing possibility that pathogenic 10 Δ CHMP2B mutants might directly prevent synaptic potentiation and/or weaken previously strong synapses and thereby perturb the functional connectivity of neurones. Further experiments are required to determine the role of CHMP2B and the impact of CHMP2B mutants on activity-dependent changes of spine structure, such as the enlargement associated with long-term potentiation.
While lethal perturbation of autophagy may explain the loss of cortical neurones at the symptomatic stage of FTD-3 (Lee and Gao, ; ), the protracted course of the disease, the lack of toxicity displayed by disease-linked mutants such as CHMP2B 2009 Urwin et al., 2010 , and the low level of mutant CHMP2B mRNA in patients brain lead one to argue that CHMP2B mutants may initially have pathogenic effects other than dysfunctional autophagy leading to cell death. Our results suggest that in FTD-3 as in Alzheimer s disease, ' the pathogenic proteins may perturb synaptic plasticity and microstructure, long before overt cell death. A synaptotoxic mechanism would be consistent with observations of synapse loss in FTD ( ; ) and the widespread abnormalities in spine Ferrer, 1999 Lipton et al., 2001 8 18 density and morphology seen in diverse neurodegenerative diseases ( ; ). Understanding how defects Fiala et al., 2002 Wishart et al., 2006 in the highly conserved CHMP2B protein specifically lead to cortical degeneration may shed light on fundamental mechanisms of normal and pathological neurobiology. lack of LC3-GFP clustering in neurones expressing mutant CHMP2B. Neurones were co-transfected at 10 DIV with the indicated CHMP2B plasmids (left), together with the autophagosomal marker LC3-GFP. The cells were fixed 5 days later and processed for immunofluorescence staining with anti-tag antibody and Alexa594-coupled secondary antibody. Confocal images were acquired in both the immunofluorescence and GFP channels. Diffuse LC3-GFP localisation predominated upon cotransfection with CHMP2B (a1,a2), CHMP2B (c1,c2) and in a wt 10 Δ large majority of cases with CHMP2B (b1,b2). Autophagosome accumulation was seen in rare cells transfected with CHMP2B (b3,   intron5  intron5 b4, arrow). Arrowhead: no autophagosomes were detected in the dendrites. Scale bars: 10 m.
μ Fig. 3 non-endosomal localisation of exogenously expressed CHMP2B proteins in hippocampal neurones. The neurones were doubly stained with monoclonal anti-tag antibody (a1 f1) together with polyclonal antibody against the respective marker (a2-f2), as indicated. Immunofluorescence was recorded by dual-channel confocal microscopy. Arrows indicate CHMP2B puncta. Note that they do not coincide with EEA1 (a2 c2) or LAMP1 (d2 f2) puncta. Scale bar: 10 m. effects of FTD-linked CHMP2B mutants on the density and dimensions of spines. All parameters were measured on the same sets of neurones (pooled from 3 independent cultures). Ctrl: control plasmid (n 31 neurones); wt: tagged wild-type CHMP2B (n 33 neurones); i5: CHMP2B depletion had no effect on the mean spine length per neuron. D: cumulative frequency histogram of spine lengths. E: mean spine head diameter per neurone. The CHMP2B shRNA induces a highly significant decrease ( p<0.001) which is rescued by re-expression of CHMP2B * (ns, p 0.19). F: cumulative frequency histogram of spine head diameters. G: normalized distribution of spine head diameters. Note the = superposition of control and rescued curves, and the recovery of larger spines in the rescued profile. H: proportions of basic spine types.
The CHMP2B shRNA potently decreases the mushroom spine fraction ( p<0.001) and the effect is suppressed in the rescued cells (ns, p * = 0.028, corrected alpha 0.017).
= Fig. 10 effect of mutant CHMP2B on the subcellular distribution of the normal protein. Hippocampal neurones were transfected with the indicated mutant, and processed for dual immunofluorescent staining with anti-tag and anti-endogenous CHMP2B antibodies. Confocal images were acquired in both channels. Co-clustering of endogenous CHMP2B with mutant protein (arrows) was evident in some of the CHMP2B intron5
aggregates (upper panel), and faintly discernible in some of the CHMP2B puncta (lower panel). Scale bars: 10 m.
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